Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

People take part in a demonstration against Brazilian President Jair Bolsonaro's handling of the COVID-19 pandemic in Sao Paulo, Brazil, on July 3. Photo: Miguel Schincariol/AFP via Getty Images

Thousands of protesters across Brazil called for President Jair Bolsonaro's removal Saturday, one day after a judge authorized opening an investigation into him over an alleged COVID-19 vaccine procurement scheme, per the Guardian.

Why it matters: The pandemic has killed almost 524,000 people in Brazil amid a slow vaccine rollout. This investigation, along with a Senate probe, may hurt Bolsonaro's re-election chances next year and could hamper his "ability to serve out the remainder of his term," the New York Times notes.

An anti-Bolsonaro protest in Brasilia on July 3. "The president has been implicated in allegations of irregularities surrounding a 1.6 billion reais ($316 million) contract signed in February for 20 million doses with a Brazilian intermediary for the vaccine's maker, Bharat Biotech," Reuters reports. Photo: Sergio Lima/AFP via Getty Images
A woman holds a sign depicting Bolsonaro on a dollar bill during a protest in downtown Rio de Janeiro on July 3. Photo: Andre Borges/AFP via Getty Images
People at the anti-Bolsonaro demonstration in Brasilia on July 3. Photo: Sergio Lima/AFP via Getty Images
A man dressed as the Brazilian vaccine symbol takes part in a demonstration against Bolsonaro in Sao Paulo, on July 3. Photo: Miguel Schincariol/AFP via Getty Images
The scene at the anti-Bolsonaro protest in downtown Rio de Janeiro on July 3. Photo: Andre Borges/AFP via Getty Images

Go deeper

Oct 11, 2021 - Health

Texas Gov. Greg Abbott bans COVID-19 vaccine mandates by any entity

Greg Abbott. Photo: Sergio Flores/Bloomberg via Getty Images

Texas Gov. Greg Abbott issued an executive order Monday prohibiting COVID-19 vaccine mandates by any "entity," including employers, if someone objects to the vaccine for "any reason of personal conscience."

Why it matters: The new executive order goes further than the Republican governor's previous vaccine mandate ban passed in August, which prohibited vaccine mandates by any state government entity or entities that received public funds.

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Mix-and-matching gains momentum — Boosters overtake first doses in U.S. — Pfizer to vaccinate Brazilian cityPanel endorses J&J booster.
  2. Health: Age is still a huge coronavirus risk factor — Unvaccinated 11x more likely to die from COVID — 5x more police officers died from COVID than guns.
  3. Politics: Over 30 states limited public health powers — Pope Francis calls on companies to release vaccine patents — Melbourne, "world's most locked-down city," to lift stay-at-home orders.
  4. Education: Education secretary reveals limits to Biden’s mask push on states — LA extends deadline for school employee vaccinations — Parent sues Wisconsin school district after child tests positive.
  5. Variant tracker: Where different strains are spreading.
Oct 11, 2021 - Health

Merck seeks FDA approval for antiviral COVID pill

Merck signage outside the company's headquarters in Kenilworth, New Jersey, in January 2021. Photo: Christopher Occhicone/Bloomberg via Getty Images

Merck said Monday it submitted an application to the Food and Drug Administration for an emergency use authorization for molnupiravir, its experimental antiviral COVID-19 treatment.

Why it matters: An oral antiviral drug designed to prevent or treat COVID-19 could be a key tool to combat the pandemic, and Merck's drug, which it developed with Ridgeback Biotherapeutics, could be the first one authorized in the United States.